Prot #NDS-NHL-001: A Global, Non-Interventional, Retrospective, Multi-Center Study To Generate Real-World Evidence Of Treatment Outcomes In Subjects With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/18/19 → 9/18/24

Funding

  • Quintiles, Inc. (Prot #NDS-NHL-001 // Prot #NDS-NHL-001)
  • Celgene Corporation (Prot #NDS-NHL-001 // Prot #NDS-NHL-001)